Suzuken CoTSE:9987 +0.53%73 Days Payable is 123.20 as of Mar. 2026, which is 4% above its 10-year median of 118.12. GuruFocus rates TSE:9987 with a GF Score™ of 73/100 and a GF Value™ of 円5,910.76 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 115 Medical Distribution companies, Suzuken Co ranks better than 71.3% on this metric.
Suzuken Co's average Accounts Payable for the
three
months ended in Mar. 2026 was 円746,713 Mil. Suzuken Co's Cost of Goods Sold for the
three
months ended in Mar. 2026 was 円553,083 Mil.
Hence, Suzuken Co's Days Payable for the
three
months ended in Mar. 2026 was 123.20.
The historical rank and industry rank for Suzuken Co's Days Payable or its related term are showing as below:
TSE:9987'
s Days Payable Range Over the Past 10 Years
Min: 103.54 Med: 118.12 Max: 134.96
Current: 110.74
During the past 13 years, Suzuken Co's highest Days Payable was 134.96. The lowest was 103.54. And the median was 118.12.
TSE:9987's Days Payable is ranked better than 71.3% of 115
companies
in the Medical Distribution industry
Industry Median: 79.81
vs TSE:9987: 110.74
Suzuken Co's Days Payable
declined
from Mar. 2025 (128.30) to Mar. 2026 (123.20).
It may suggest that Suzuken Coaccelerated paying its suppliers.
Suzuken Co Days Payable Related Terms
Suzuken Co Days Payable Historical Data
* Premium members only.
The historical data trend for Suzuken Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9987 vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, Suzuken Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzuken Co Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Suzuken Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Suzuken Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Suzuken Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzuken Co (TSE:9987) has a Days Payable of 123.20 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Suzuken Co and its competitors. This is near median its historical median of 118.12. Over the past decade, Suzuken Co's Days Payable has ranged from 103.54 to 134.96. According to the industry distribution chart, Suzuken Co ranks #33 out of 115 companies in the Medical Distribution industry, placing it in the top 28.7%.
Is Suzuken Co's Days Payable too high?
Suzuken Co's current Days Payable of 123.20 is near median its 10-year median of 118.12. Over the past 10 years, this metric has ranged from a low of 103.54 to a high of 134.96. The Medical Distribution industry median Days Payable is 79.81. Suzuken Co's value of 123.20 is 54.4% above this industry median. Based on the distribution chart, Suzuken Co ranks #33 out of 115 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Suzuken Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzuken Co's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Suzuken Co ranks #33 out of 115 companies for Days Payable. This puts Suzuken Co in the upper half of its industry. The industry median Days Payable is 79.81. Suzuken Co's value of 123.20 is 54.4% above this benchmark. Historically, Suzuken Co's own Days Payable has ranged from 103.54 to 134.96 over the past decade. While the company's 10-year median is 118.12 vs. the industry median of 79.81, Suzuken Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.81, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzuken Co's current Days Payable of 123.20 is 54.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Suzuken Co and its competitors. For the Medical Distribution industry, the median Days Payable is 79.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzuken Co's current Days Payable is 123.20, which is near median its own 10-year median of 118.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzuken Co stock overvalued right now?
Based on GuruFocus' analysis, Suzuken Co (TSE:9987) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,910.76, compared to a current price of 円4,950.00 — trading 16.3% below its estimated fair value. The current Days Payable is 123.20, which is near median its 10-year median of 118.12 and 54.4% above the Medical Distribution industry median of 79.81. Suzuken Co's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Suzuken Co (TSE:9987), the current Days Payable is 123.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzuken Co (TSE:9987) Overvalued in 2026?
Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued.
The current stock price of 円4,950.00 is trading 16.3% below its estimated GF Value™ of 円5,910.76.
GuruFocus considers Suzuken Co to be Modestly Undervalued.
Key valuation signals for TSE:9987:
Days Payable: 123.20 (near median its 10-year median of 118.12)
GF Value™: 円5,910.76 vs. price of 円4,950.00 (16.3% below fair value)
Industry Position: 54.4% above the Medical Distribution median (#33 of 115)
No single metric tells the full story. See the TSE:9987 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.
73GF Score
Get the complete analysis for TSE:9987
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9987 has been successfully added to your 
